Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke (Q24245166)

Cochrane Database of Systematic Reviews

Europe PubMed Central

title

Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke (English)

0 references

1 reference

2

Nikola Sprigg

0 references

author name string

Philip MW Bath

series ordinal

1

0 references

Tim England

series ordinal

3

0 references

publication date

18 April 2007

0 references

published in

0 references

cites work

Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005207.PUB3

Colony stimulating factor-1 potentiates neuronal survival in cerebral cortex ischemic lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005207.PUB3

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005207.PUB3

Modulated generation of neuronal cells from bone marrow by expansion and mobilization of circulating stem cells with in vivo cytokine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005207.PUB3

Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005207.PUB3

G-CSF reduces infarct volume and improves functional outcome after transient focal cerebral ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005207.PUB3

G-CSF suppresses edema formation and reduces interleukin-1beta expression after cerebral ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005207.PUB3

Stem cell factor stimulates neurogenesis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005207.PUB3

G-CSF protects human cerebral hybrid neurons against in vitro ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005207.PUB3

Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005207.PUB3

Derivatives of erythropoietin that are tissue protective but not erythropoietic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005207.PUB3

Intracarotid injection of granulocyte-macrophage colony-stimulating factor induces neuroprotection in a rat transient middle cerebral artery occlusion model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005207.PUB3

Granulocyte colony-stimulating factor induces sensorimotor recovery in intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005207.PUB3

Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005207.PUB3

Granulocyte-macrophage colony-stimulating factor-induced arteriogenesis reduces energy failure in hemodynamic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005207.PUB3

The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005207.PUB3

A role for G-CSF (granulocyte-colony stimulating factor) in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005207.PUB3

Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005207.PUB3

Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005207.PUB3

Beneficial effect of pharmacological mobilization of bone marrow in experimental cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005207.PUB3

Macrophage colony stimulating factor prevents NMDA-induced neuronal death in hippocampal organotypic cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005207.PUB3

Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005207.PUB3

Serum macrophage colony-stimulating factor (M-CSF) level is elevated in patients with old cerebral infarction related to vascular damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005207.PUB3

inferred from DOI database lookup

7 January 2021

based on heuristic

Erythropoietin therapy for acute stroke is both safe and beneficial

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005207.PUB3

inferred from DOI database lookup

7 January 2021

based on heuristic

Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005207.PUB3